Trials / Completed
CompletedNCT04066218
Sexual Function Screening in Childhood Cancer Survivors
Assessing Patient Preferences and a Clinical Tool for Evaluating for Sexual Function in Adolescent and Young Adult Survivors of Childhood Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 15 Years – 24 Years
- Healthy volunteers
- Not accepted
Summary
This is a qualitative research study involving semistructured interviews and Think-Aloud methodology during completion of a clinical screening tool. All participants will undergo the same semistructured interviews.
Detailed description
The proposed research will explore patient-centered approaches to evaluating younger Adolescent/young adult Childhood cancer survivors for sexual dysfunction, including strategies for implementation and usability of thePatient-Reported Outcomes Measurement Information® v2.0 Brief Profile for Sexual Function and Satisfaction Brief, an existing adult screening tool. This study will include interviews with 24 patients age 15-24 who were diagnosed with cancer prior to age 18, and treated with chemotherapy, radiation and/or surgery and are now at least two years off therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Interviews | * Participation will serve as verbal consent. * Qualitative PRA will call participant to schedule either phone or in person interview. If via phone, the study PRA performing the interview, will remind them to find a private space to speak. * REDCap link will be sent for PROMIS SexFS Brief. * PRA will perform semistructured interview and guide Think-Aloud to complete the PROMIS SexFS Brief. * Participants will not submit responses to PROMIS SexFS Brief responses after completing the tool. |
Timeline
- Start date
- 2019-09-16
- Primary completion
- 2020-04-07
- Completion
- 2022-06-01
- First posted
- 2019-08-26
- Last updated
- 2022-06-30
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04066218. Inclusion in this directory is not an endorsement.